Beauty Health CEO receives 2.65M RSU equity grant

Malha Pedro Bruno Ferreira reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Malha Pedro Bruno Ferreira reported acquisition or exercise transactions in this Form 4 filing.

Beauty Health Co reported that President and CEO Pedro Bruno Ferreira Malha received a grant of 2,654,867 restricted stock units (RSUs) of Class A Common Stock as equity compensation. Each RSU represents one share of stock and vests in three equal annual installments starting on the first anniversary of the March 20, 2026 grant date, subject to continued service and certain acceleration rights.

After this award, Malha is shown as beneficially owning 4,845,251 shares of Class A Common Stock directly. The transaction was recorded at a price of $0.00 per share, reflecting that it is a compensation grant rather than an open-market purchase.

Insights

Equity compensation and governance analyst

Large RSU grant to the CEO is compensation-driven, not a market purchase.

The filing shows Pedro Bruno Ferreira Malha, President and CEO of Beauty Health Co, receiving 2,654,867 RSUs at $0.00 per share. This is a stock-based compensation award, not an open-market transaction, and does not involve cash paid by the insider.

The award vests in one-third increments on each of the first three anniversaries of the March 20, 2026 grant date, contingent on continued service and certain acceleration rights. This structure is designed to align leadership with shareholder outcomes over several years, though actual dilution and cost depend on future vesting and settlement.

Insider Trade Summary

Grant/Award: 2,654,867 shares

Grant/Award 1 txn

Insider Malha Pedro Bruno Ferreira

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	2,654,867	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 4,845,251 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock of The Beauty Health Company (the "Company"). The RSUs are subject to time-vesting conditions. The RSUs vest in one-third increments on each of the first three anniversaries of the grant date of March 20, 2026, in each case subject to continued service with the Company through the vesting date and certain acceleration rights.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Beauty Health Co (SKIN) report in this Form 4 filing?

Beauty Health Co reported that President and CEO Pedro Bruno Ferreira Malha received a grant of 2,654,867 restricted stock units of Class A Common Stock as equity compensation, which will vest over time subject to continued service and certain acceleration rights.

How many RSUs did SKIN’s CEO Pedro Malha receive in this award?

Pedro Malha received 2,654,867 restricted stock units. Each RSU represents a contingent right to one share of Class A Common Stock, subject to vesting conditions tied to continued service with Beauty Health Co and specified acceleration provisions in the award terms.

What are the vesting terms of the RSUs granted to SKIN’s CEO?

The RSUs vest in one-third increments on each of the first three anniversaries of the March 20, 2026 grant date. Vesting is conditioned on continued service with Beauty Health Co through each vesting date and is also subject to certain specified acceleration rights described in the award.

Is the Form 4 transaction for SKIN’s CEO a stock purchase or compensation grant?

The transaction is a compensation grant, not an open-market purchase. The Form 4 lists the code “A” for a grant or award, and the shares were recorded at a price of $0.00 per share, consistent with restricted stock units issued as part of an equity compensation package.

How many Beauty Health Co shares does the CEO hold after this RSU grant?

Following this award, Pedro Malha is shown as directly holding 4,845,251 shares of Class A Common Stock. This figure reflects his reported beneficial ownership after the RSU grant, as disclosed in the Form 4’s post-transaction holdings column for non-derivative securities.

Does the RSU grant to SKIN’s CEO involve any cash changing hands?

No cash changes hands in this RSU grant. The Form 4 shows a transaction price of $0.00 per share, indicating that the CEO did not pay cash; instead, the award represents stock-based compensation that may settle in shares upon vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/24/2026 - 05:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Malha Pedro Bruno Ferreira

(Last) (First) (Middle)

C/O THE BEAUTY HEALTH COMPANY

3600 E. BURNETT STREET

(Street)

LONG BEACH CALIFORNIA 90815

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Beauty Health Co [ SKIN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/20/2026		A(1)		2,654,867	A	(1)	4,845,251	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock of The Beauty Health Company (the "Company"). The RSUs are subject to time-vesting conditions. The RSUs vest in one-third increments on each of the first three anniversaries of the grant date of March 20, 2026, in each case subject to continued service with the Company through the vesting date and certain acceleration rights.

Remarks:

	/s/ Paul Bokota, Attorney-in-Fact for Pedro Bruno Ferreira Malha	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)